Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:galactosylceramide catabolic process
go back to main search page
Accession:GO:0006683 term browser browse the term
Definition:The chemical reactions and pathways resulting in the breakdown of galactosylceramides, any compound formed by the replacement of the glycosidic hydroxyl group of a cyclic form of galactose by a ceramide group.
Synonyms:exact_synonym: galactosylceramide breakdown;   galactosylceramide catabolism;   galactosylceramide degradation


show annotations for term's descendants       view all columns           Sort by:
 
galactosylceramide catabolic process term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Galc galactosylceramidase JBrowse link 6 122,177,195 122,239,411 RGD:1624291
RGD:13792537
G Gba3 glucosylceramidase beta 3 JBrowse link 14 64,390,793 64,535,213 RGD:1624291
G Psap prosaposin JBrowse link 20 29,831,302 29,856,876 RGD:1600115
RGD:1624291

Term paths to the root
Path 1
Term Annotations click to browse term
  biological_process 19312
    metabolic process 11535
      organic substance metabolic process 10932
        carbohydrate derivative metabolic process 1005
          carbohydrate derivative catabolic process 137
            glycolipid catabolic process 17
              galactolipid catabolic process 4
                galactosylceramide catabolic process 3
Path 2
Term Annotations click to browse term
  biological_process 19312
    metabolic process 11535
      primary metabolic process 10404
        lipid metabolic process 1295
          cellular lipid metabolic process 981
            membrane lipid metabolic process 178
              sphingolipid metabolic process 130
                ceramide metabolic process 90
                  glycosylceramide metabolic process 18
                    galactosylceramide metabolic process 10
                      galactosylceramide catabolic process 3
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.